PuSH - Publikationsserver des Helmholtz Zentrums München

Bunz, H. ; Tschritter, O.* ; Haap, M.* ; Riessen, R.* ; Heyne, N. ; Artunc, F.

Elimination of contrast agent gadobutrol with sustained low efficiency daily dialysis compared to intermittent hemodialysis.

Kidney Blood Press. Res. 44, 1363-1371 (2019)
Verlagsversion DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Background: In patients with renal failure, gadolinium-based contrast agents (GBCA) can be removed by intermittent hemodialysis (iHD) to prevent possible toxic effects. There is no data on the efficacy of GBCA removal via sustained low efficiency daily dialysis (SLEDD) which is mainly used in intensive care unit (ICU) patients. Methods: We compared the elimination of the GBCA gadobutrol in 6 ICU patients treated with SLEDD (6-12 h, 90 L dialysate) with 7 normal ward inpatients treated with iHD (4 h, dialysate flow 500 mL/min). Both groups received 3 dialysis sessions on 3 consecutive days starting after the application of gadobutrol. Blood samples were drawn before and after each session and total dialysate, as well as urine was collected. Gadolinium (Gd) concentrations were measured using mass spectrometry and eliminated Gd was calculated from dialysate and urine. Results: The initial mean plasma Gd concentration was 385 +/- 183 mu M for the iHD and 270 +/- 97 mu M for the SLEDD group, respectively (p > 0.05). The Gd-reduction rate after the first dialysis session was 83 +/- 9 and 67 +/- 9% for the iHD and the SLEDD groups, respectively (p = 0.0083). The Gd-reduction rate after the second and third dialysis was 94-98 and 89-96% for the iHD and the SLEDD groups (p > 0.05). The total eliminated Gd was 89 +/- 14 and 91 +/- 4% of the dose in the iHD and the SLEDD groups, respectively (p > 0.05). Gd dialyzer clearance was 95 +/- 22 mL/min and 79 +/- 19 mL/min for iHD and SLEDD, respectively (p > 0.05). Conclusions: Gd-elimination with SLEDD is equally effective as iHD and can be safely used to remove GBCA in ICU patients.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter Intermittent Hemodialysis ; Elimination Of Contrast Agent Gadobutrol ; Sustained Low Efficiency Daily Dialysis; Acute Kidney Injury; Nephrogenic Systemic Fibrosis; Glomerular-filtration-rate; Critically-ill Patients; Gadolinium; Disease; Safety; Mri
ISSN (print) / ISBN 1420-4096
e-ISSN 1423-0143
Zeitschrift Kidney & Blood Pressure Research
Quellenangaben Band: 44, Heft: 6, Seiten: 1363-1371 Artikelnummer: , Supplement: ,
Verlag Karger
Verlagsort Allschwilerstrasse 10, Ch-4009 Basel, Switzerland
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Diabetes Research and Metabolic Diseases (IDM)